Form 4: Immunome Executive Sells Shares
Insider Transaction (Form 4)
Jack Higgins, Chief Scientific Officer of Immunome Inc., sold 13,200 shares of common stock on September 11, 2026 for $25.32 per share.
Summary
- Option exercise/conversion: acquired 18,000 Common Stock at $1.35 ($24,300) on September 11, 2026; holds 78,250 after (Direct).
- Open-market sale: disposed of 13,200 Common Stock at $25.32 ($334,224) on September 11, 2026; holds 65,050 after (Direct).
- Bona fide gift: disposed of 8,800 Common Stock on September 11, 2026; holds 56,250 after (Direct).
- Option exercise/conversion: acquired 18,000 Employee Stock Option (right to buy) on September 11, 2026; holds 133,840 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $334,224 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jack Higgins — Officer (Chief Scientific Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Option exercise/conversion | Common Stock | 18,000 | $1 | $24.3K | 78,250 |
| 2026-09-11 | Open-market sale | Common Stock | 13,200 | $25 | $334.2K | 65,050 |
| 2026-09-11 | Bona fide gift | Common Stock | 8,800 | — | — | 56,250 |
| 2026-09-11 | Option exercise/conversion | Employee Stock Option (right to buy) | 18,000 | — | — | 133,840 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Option exercise/conversion (18,000 shares) |
| 2026-09-11 | Open-market sale (13,200 shares) |
| 2026-09-11 | Bona fide gift (8,800 shares) |
| 2026-09-11 | Option exercise/conversion (18,000 shares) |
Keywords
insider transaction, Form 4, IMNM, Immunome Inc., bearish, Jack Higgins
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.